Wells Fargo’s BioLineRX BLRX Stock Holding History

Wells Fargo’s Portfolio BLRX Stock Details BLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.03K	Hold	1,750	–	–	﹤0.01%	6165
2025 Q4	$4.85K	Hold	1,750	–	–	﹤0.01%	6102
2025 Q3	$6.62K	Hold	1,750	–	–	﹤0.01%	6024
2025 Q2	$8K	Sell	1,750 -1,250	-42%	-$4.62K	﹤0.01%	6002
2025 Q1	$8.88K	Buy	3,000 +2,862	+2,074%	+$11.5K	﹤0.01%	5910
2024 Q4	$1.18K	Sell	138 -738	-84%	-$10.9K	﹤0.01%	6244
2024 Q3	$18.8K	Sell	876 -525	-37%	-$14.4K	﹤0.01%	5655
2024 Q2	$31.9K	Buy	1,401 +600	+75%	+$16.1K	﹤0.01%	5445
2024 Q1	$35.9K	Buy	801 +588	+276%	+$29.5K	﹤0.01%	5380
2023 Q4	$13.4K	Hold	213	–	–	﹤0.01%	5750
2023 Q3	$15.5K	Buy	213 +212	+21,200%	+$14.2K	﹤0.01%	5685
2023 Q2	$56	Hold	1	–	–	﹤0.01%	7029
2023 Q1	$31	Hold	1	–	–	﹤0.01%	7242
2022 Q4	$21	Hold	1	–	–	﹤0.01%	7265
2022 Q3	$0	Hold	1	–	–	﹤0.01%	6676
2022 Q2	$0	Hold	1	–	–	﹤0.01%	6814
2022 Q1	$0	Sell	1 -17	-94%	-$1.18K	﹤0.01%	7071
2021 Q4	$1K	Hold	18	–	–	﹤0.01%	6965
2021 Q3	$2K	Hold	18	–	–	﹤0.01%	6552
2021 Q2	$2K	Hold	18	–	–	﹤0.01%	6526
2021 Q1	$2K	Buy	18 +17	+1,700%	+$2.04K	﹤0.01%	6624
2020 Q4	$0	Hold	1	–	–	﹤0.01%	6494
2020 Q3	$0	Hold	1	–	–	﹤0.01%	6341
2020 Q2	$0	Hold	1	–	–	﹤0.01%	6290
2020 Q1	$0	Hold	1	–	–	﹤0.01%	6202
2019 Q4	$0	Sell	1 -67	-99%	-$6.9K	﹤0.01%	6355
2019 Q3	$7K	Hold	68	–	–	﹤0.01%	5999
2019 Q2	$15K	Hold	68	–	–	﹤0.01%	5833
2019 Q1	$17K	Hold	68	–	–	﹤0.01%	5560
2018 Q4	$18K	Buy	68 +67	+6,700%	+$32.3K	﹤0.01%	5801
2018 Q3	$1K	Hold	1	–	–	﹤0.01%	6278
2018 Q2	$0	Sell	1 -2	-67%	-$1.06K	﹤0.01%	6325
2018 Q1	$2K	Buy	+3	New	+$1.84K	﹤0.01%	6183
2017 Q4	–	Sell	-2	Closed	-$1K	–	6346
2017 Q3	$1K	Hold	2	–	–	﹤0.01%	6209
2017 Q2	$1K	Hold	2	–	–	﹤0.01%	6099
2017 Q1	$1K	Hold	2	–	–	﹤0.01%	6211
2016 Q4	$1K	Hold	2	–	–	﹤0.01%	6147
2016 Q3	$1K	Hold	2	–	–	﹤0.01%	6095
2016 Q2	$1K	Hold	2	–	–	﹤0.01%	5993
2016 Q1	$1K	Hold	2	–	–	﹤0.01%	6083
2015 Q4	$1K	Hold	2	–	–	﹤0.01%	6079
2015 Q3	$2K	Hold	2	–	–	﹤0.01%	5976
2015 Q2	$3K	Hold	2	–	–	﹤0.01%	6090
2015 Q1	$2K	Hold	2	–	–	﹤0.01%	5965
2014 Q4	$2K	Hold	2	–	–	﹤0.01%	6006
2014 Q3	$2K	Hold	2	–	–	﹤0.01%	5982
2014 Q2	$2K	Hold	2	–	–	﹤0.01%	5940
2014 Q1	$2K	Hold	2	–	–	﹤0.01%	5672
2013 Q4	$3K	Hold	2	–	–	﹤0.01%	5465
2013 Q3	$2K	Hold	2	–	–	﹤0.01%	5436
2013 Q2	$2K	Buy	+2	New	+$2.07K	﹤0.01%	5365

Other funds holding BLRX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Wells Fargo's BLRX Position: Q1 2026 in Review

Wells Fargo held its BioLineRX (BLRX) position steady in Q1 2026 at 1,750 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #6165.

Wells Fargo first reported a position in BLRX in Q2 2013 and has held it in 51 quarters since. The position peaked at $35.9K in Q1 2024. 13 funds tracked by Wall St. Rank hold BLRX as of Q1 2026.

Wells Fargo held 1,750 shares of BioLineRX worth $4.03K as of Q1 2026.
Wells Fargo left its BioLineRX share count unchanged in Q1 2026.
BioLineRX made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6165 holding.
Wells Fargo first reported a position in BioLineRX in Q2 2013 and has held it in 51 quarters since.
Wells Fargo's BioLineRX position peaked at $35.9K in Q1 2024.
13 funds tracked by Wall St. Rank held BioLineRX as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.